Back

Risk stratification for ischemic and bleeding events in patients using a potent P2Y12 inhibitor

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Coronary artery disease: pharmacotherapy Thrombosis, Platelets, and Coagulation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Yong Whi Park

Gyeongsang National University Hospital, Changwon (Korea (Republic of))

9 More presentations in this session

Presentation thumbnail
Clinical effects of beta blocker selectivity and dosage regimens in acute myocardial infarction: propensity-score matching analysis
Professor U. Kim (Daegu, KR)
Abstract Slides
Presentation thumbnail
Three for two - a meta-analysis on the optimal antithrombotic regimen in patients undergoing coronary stent implantation with an indication to anticoagulation therapy
Doctor F. Fortuni (Perugia, IT)
Abstract
Presentation thumbnail
Patients eligible for prolonged dual antiplatelet treatment one year after acute coronary syndrome according to the of PRECISE-DAPT score and DAPT score
Doctor A. Cordero (Alicante, ES)
Abstract Slides
Presentation thumbnail
Single agent clopidogrel is associated with increased all cause mortality compared with aspirin only treatment.
Mr V. Parmar (Bushey, GB)
Abstract
Presentation thumbnail
Validity of DAPT score to predict late ischemic and hemorrhagic events in patients with ST-segment-elevation acute coronary syndrome
Doctor I. Ferreira Gonzalez (Barcelona, ES)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Coronary artery disease: pharmacotherapy

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources